Cite
Finerenone: A Potential Treatment for Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus.
MLA
D’Marco, Luis, et al. “Finerenone: A Potential Treatment for Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus.” TouchREVIEWS in Endocrinology, vol. 17, no. 2, Nov. 2021, pp. 84–87. EBSCOhost, https://doi.org/10.17925/EE.2021.17.2.84.
APA
D’Marco, L., Puchades, M. J., Gandía, L., Forquet, C., Giménez-Civera, E., Panizo, N., Reque, J., Juan-García, I., Bermúdez, V., & Gorriz, J. L. (2021). Finerenone: A Potential Treatment for Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus. TouchREVIEWS in Endocrinology, 17(2), 84–87. https://doi.org/10.17925/EE.2021.17.2.84
Chicago
D’Marco, Luis, María Jesús Puchades, Lorena Gandía, Claudia Forquet, Elena Giménez-Civera, Nayara Panizo, Javier Reque, Isabel Juan-García, Valmore Bermúdez, and José Luis Gorriz. 2021. “Finerenone: A Potential Treatment for Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus.” TouchREVIEWS in Endocrinology 17 (2): 84–87. doi:10.17925/EE.2021.17.2.84.